AzTrials
AzTrials

StrokeHOMEMUSICNCT04507542

Enriched Music-Supported Therapy to Restore Motor Deficits After Stroke

A study testing Enriched Music-Supported Therapy and Graded Repetitive Arm Supplementary Program in people with Stroke, run by University of Barcelona at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Music-Supported Therapy (MST) is a rehabilitation technique to improve the upper extremity motor function of stroke patients through playing musical instruments. A modified version of the MST protocol has been created (hereafter, referred as enriched MST, eMST) to include (i) a home-based self-training program using… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
Enriched Music-Supported Therapy and Graded Repetitive Arm Supplementary Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSpain
Study dates
1 Sep 2020to 1 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Presence of mild-to-moderate paresis of the upper extremity after a stroke (having a score between 1 and 4 in the Medical Research Council Scale for Muscle Strength at the distal muscles of the upper extremity);
  • More than 6 months post-stroke;
  • Completion of formal rehabilitation programs.

Who cannot join

  • Major language or cognitive deficits affecting comprehension (Mini-Mental State Examination < 24);
  • Neurological or psychiatric co-morbidity;
  • Other musculoskeletal condition affecting upper extremity motor function (e.g. fracture or arthritis).

Trial locations and contacts

1 site in 1 country.

Antoni Rodríguez Fornells, PhD contact

+34934020489

antoni.rodriguez@icrea.cat

Jennifer Grau Sánchez, PhD contact

+34934020489

jennifergrau@euit.fdsll.cat

Spain1 site
  • Bellvitge Biomedical Research Institute

    L'Hospitalet de Llobregat, Barcelona, 08908

    Research Office, +34932607411

Other trials in Spain

About this study

Official title: Playing and Singing for the Recovering Brain: Efficacy of Enriched Social-Motivational Musical Interventions in Stroke Rehabilitation

Music-Supported Therapy (MST) is a rehabilitation technique to improve the upper extremity motor function of stroke patients through playing musical instruments. A modified version of the MST protocol has been created (hereafter, referred as enriched MST, eMST) to include (i) a home-based self-training program using an app for electronic tablets and (ii) weekly group sessions of musical playing strengthening the motivational and emotional components of music playing. A randomised controlled trial will be conducted to test the effectiveness of this enriched MST (eMST) protocol in improving motor functions, cognition, emotional well-being and quality of life when compared to a program of home-based exercises utilizing the Graded Repetitive Arm Supplementary Program (GRASP). Sixty stroke patients will be recruited and randomly allocated to an eMST group (n=30) or a control GRASP intervention group (n=30). Patients will be evaluated before and after a 10-week intervention, as well as at 3-month follow-up. The primary outcome of the study is the functionality of the paretic upper limb measured with the Action Research Arm Test. Secondary outcomes include other motor and cognitive functions, emotional well-being and quality of life measures as well as self-regulation and self-efficacy outcomes. We hypothesize that patients treated with eMST will show larger improvements in their motor and cognitive functions, emotional well-being and quality of life than patients treated with a home-based GRASP intervention.

Conditions
Stroke
Being tested
Enriched Music-Supported Therapy, Graded Repetitive Arm Supplementary Program
Keywords
stroke, rehabilitation, music therapy
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enriched Music-Supported TherapyBehavioural

    Also called Music-Supported Therapy

    Home-based rehabilitation program for stroke patients aimed at improving the upper extremity motor function. The program is based on musical training, combining self-training sessions of music playing using an app for electronic tablets and music therapy group sessions.

  • Graded Repetitive Arm Supplementary ProgramBehavioural

    Also called GRASP

    Home-based rehabilitation program for stroke patients aimed at improving the upper extremity motor function. The program comprises self-training sessions of mass repetition of movements and task-specific exercises for the upper extremity.

Study groups in NCT04507542
Study groupRoleWhat they receive
Enriched Music-Supported Therapy groupExperimentalParticipants in the eMST-group will follow a 10-week program of Enriched Music-Supported Therapy. The program comprises 3 individual self-training sessions and 1 group session per week (total program duration: 40 hours).
Receives: Behavioral: Enriched Music-Supported Therapy
Control groupActive comparatorParticipants in the control intervention group will follow the Graded Repetitive Arm Supplementary Program (GRASP, Harris et al., 2009). They will be asked to complete 4 weekly one-hour session for 10 weeks (total program duration: 40 hours).
Receives: Behavioral: Graded Repetitive Arm Supplementary Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Action Research Arm Test

    Upper extremity function measure. The measure is a 19-item test divided into four subtests (grasp, grip, pinch and gross movement). For each item, the patient is asked to perform a simple task that involves a functional movement of the affected upper limb. Each task is rated using a 4-point ordinal scale. The maximum possible score is 57 and the minimal clinically important difference is 5.7 points.

    Measured: immediately after the intervention

  2. Change in Action Research Arm Test

    Upper extremity function measure. The measure is a 19-item test divided into four subtests (grasp, grip, pinch and gross movement). For each item, the patient is asked to perform a simple task that involves a functional movement of the affected upper limb. Each task is rated using a 4-point ordinal scale. The maximum possible score is 57 and the minimal clinically important difference is 5.7 points.

    Measured: 3 months after completing the intervention

Secondary outcomes (28)
  1. Change in Fugl-Meyer Assessment of Motor Recovery after Stroke

    Motor impairment measure. It comprises 33 items that evaluate motor impairment in the affected upper limb. The test is divided into 4 sections (shoulder, forearm and elbow, wrist, hand and coordination) assessing reflexes, flexor and extensor synergies, range of motion, and overall coordination and speed of the upper extremity. Each item is graded using an ordinal scale from 0 to 2. The maximum possible score is 66 and the minimal clinically important difference for chronic stroke patients is 5.2 points.

    Measured: immediately after the intervention

  2. Change in Fugl-Meyer Assessment of Motor Recovery after Stroke

    Motor impairment measure. It comprises 33 items that evaluate motor impairment in the affected upper limb. The test is divided into 4 sections (shoulder, forearm and elbow, wrist, hand and coordination) assessing reflexes, flexor and extensor synergies, range of motion, and overall coordination and speed of the upper extremity. Each item is graded using an ordinal scale from 0 to 2. The maximum possible score is 66 and the minimal clinically important difference for chronic stroke patients is 5.2 points.

    Measured: 3 months after completing the intervention

  3. Change in Grip Strength in Kgs

    Grip strength measure, Biometrics E-Link tool

    Measured: immediately after the intervention

  4. Change in Grip Strength in Kgs

    Grip strength measure, Biometrics E-Link tool

    Measured: 3 months after completing the intervention

  5. Change in Box and Block Test

    Gross manual dexterity measure

    Measured: immediately after the intervention

  6. Change in Box and Block Test

    Gross manual dexterity measure

    Measured: 3 months after completing the intervention

  7. Change in Nine Hole Pegboard Test

    Fine manual dexterity measure

    Measured: immediately after the intervention

  8. Change in Nine Hole Pegboard Test

    Fine manual dexterity measure

    Measured: 3 months after completing the intervention

  9. Change in Chedoke Arm and Hand Activity Inventory

    Motor performance in activities of daily living measure. The test is composed of 13 different tasks (i.e. open a jar of coffee, make a phone call, clean a pair of eyeglasses) and each task is graded using an ordinal scale from 1 to 7. Maximum score is 91, indicating good performance.

    Measured: immediately after the intervention

  10. Change in Chedoke Arm and Hand Activity Inventory

    Motor performance in activities of daily living measure. The test is composed of 13 different tasks (i.e. open a jar of coffee, make a phone call, clean a pair of eyeglasses) and each task is graded using an ordinal scale from 1 to 7. Maximum score is 91, indicating good performance.

    Measured: 3 months after completing the intervention

  11. Change in Behaviour Rating Inventory of Executive Function

    Executive function measure. It comprises 75 items describing various behaviours, and the participant is asked to report if the behaviour is never a problem, sometimes a problem or often a problem.

    Measured: immediately after the intervention

  12. Change in Behaviour Rating Inventory of Executive Function

    Executive function measure. It comprises 75 items describing various behaviours, and the participant is asked to report if the behaviour is never a problem, sometimes a problem or often a problem.

    Measured: 3 months after completing the intervention

  13. Change in Sustained Attention to Response Task

    Sustained attention measure

    Measured: immediately after the intervention

  14. Change in Sustained Attention to Response Task

    Sustained attention measure

    Measured: 3 months after completing the intervention

  15. Change in Figural Memory Subtest

    Visuospatial memory measure

    Measured: immediately after the intervention

  16. Change in Figural Memory Subtest

    Visuospatial memory measure

    Measured: 3 months after completing the intervention

  17. Change in Rey Auditory Verbal Learning Test

    Verbal learning measure

    Measured: immediately after the intervention

  18. Change in Rey Auditory Verbal Learning Test

    Verbal learning measure

    Measured: 3 months after completing the intervention

  19. Change in Fluency Test

    Verbal fluency measure

    Measured: immediately after the intervention

  20. Change in Fluency Test

    Verbal fluency measure

    Measured: 3 months after completing the intervention

  21. Change in Beck Depression Inventory-II

    Depression measure. It comprises 21 multiple-choice questions that are scored on a scale from 0 to 3. The participant is asked about feelings, thoughts and behaviours of the past week. Higher scores indicate depression severity and the maximum possible score of the measure is 63.

    Measured: immediately after the intervention

  22. Change in Beck Depression Inventory-II

    Depression measure. It comprises 21 multiple-choice questions that are scored on a scale from 0 to 3. The participant is asked about feelings, thoughts and behaviours of the past week. Higher scores indicate depression severity and the maximum possible score of the measure is 63.

    Measured: 3 months after completing the intervention

  23. Change in Apathy Evaluation Scale

    Apathy measure. The scale comprises a self and informant reports both consisting of 18 items that are scored on a 4-point Likert scale, where higher scores indicate more apathy.

    Measured: immediately after the intervention

  24. Change in Apathy Evaluation Scale

    Apathy measure. The scale comprises a self and informant reports both consisting of 18 items that are scored on a 4-point Likert scale, where higher scores indicate more apathy.

    Measured: 3 months after completing the intervention

  25. Change in Profile of Mood States

    Mood measure. The measure includes 65 items that are scored on a 5-point Likert scale ranging from 0 "not at all" to 4 "extremely".

    Measured: immediately after the intervention

  26. Change in Profile of Mood States

    Mood measure. The measure includes 65 items that are scored on a 5-point Likert scale ranging from 0 "not at all" to 4 "extremely".

    Measured: 3 months after completing the intervention

  27. Change in Stroke Impact Scale

    Quality of life measure. It is a 59-item self-report questionnaire that assesses muscle strength, hand function, basic and instrumental activities of daily living, global mobility, communication, emotion, memory and thinking, and participation.

    Measured: immediately after the intervention

  28. Change in Stroke Impact Scale

    Quality of life measure. It is a 59-item self-report questionnaire that assesses muscle strength, hand function, basic and instrumental activities of daily living, global mobility, communication, emotion, memory and thinking, and participation.

    Measured: 3 months after completing the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2020
  2. Study start1 Sep 2020 (estimated)
  3. Primary completion1 Jul 2021 (estimated)
  4. Study completion1 Jul 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A parallel-group randomised controlled trial will be conducted with participants being randomised to either an enriched Music-Supported Therapy group or to a control treatment group receiving the Graded Repetitive Arm Supplementary Program (GRASP, Harris et al., 2009).
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04507542
Sponsor's protocol ID
201729.30
Acronym
HOMEMUSIC
Status last verified
Aug 2020
First submitted
3 Aug 2020
Last updated
11 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Segura E, Grau-Sanchez J, Cerda-Company X, Porto MF, De la Cruz-Puebla M, Sanchez-Pinsach D, Cerquides J, Duarte E, Palumbo A, Turry A, Raghavan P, Sarkamo T, Munte TF, Arcos JL, Rodriguez-Fornells A. Enriched music-supported therapy for individuals with chronic stroke: a randomized controlled trial. J Neurol. 2024 Oct;271(10):6606-6617. doi: 10.1007/s00415-024-12570-3. Epub 2024 Aug 7.

    PubMed 39112892
  • Grau-Sanchez J, Segura E, Sanchez-Pinsach D, Raghavan P, Munte TF, Palumbo AM, Turry A, Duarte E, Sarkamo T, Cerquides J, Arcos JL, Rodriguez-Fornells A. Enriched Music-supported Therapy for chronic stroke patients: a study protocol of a randomised controlled trial. BMC Neurol. 2021 Jan 12;21(1):19. doi: 10.1186/s12883-020-02019-1.

    PubMed 33435919

Questions about this trial

What is this clinical trial studying?

A study testing Enriched Music-Supported Therapy and Graded Repetitive Arm Supplementary Program in people with Stroke, run by University of Barcelona at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Antoni Rodríguez Fornells, PhD (+34934020489, antoni.rodriguez@icrea.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Action Research Arm Test (time frame: immediately after the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04507542, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in